|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,294.50 GBX | -0.27% |
|
+3.92% | +1.09% |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.28 | 5.34 | 7.14 | 5.03 | 4.49 | |||||
Return on Total Capital | 6.92 | 6.86 | 9.04 | 6.32 | 5.67 | |||||
Return On Equity % | 10.79 | 12.58 | 17.68 | 10.21 | 6.79 | |||||
Return on Common Equity | 10.79 | 12.58 | 17.68 | 10.14 | 6.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 43.5 | 43.14 | 43.12 | 42.93 | 42.44 | |||||
SG&A Margin | 30.84 | 31.67 | 29 | 31.05 | 30.94 | |||||
EBITDA Margin % | 14.35 | 13.62 | 15.91 | 14.24 | 13.99 | |||||
EBITA Margin % | 12.33 | 11.58 | 13.84 | 11.51 | 10.96 | |||||
EBIT Margin % | 7.86 | 7.72 | 10.24 | 7.85 | 7.4 | |||||
Income From Continuing Operations Margin % | 3.78 | 4.64 | 6.89 | 4.08 | 2.84 | |||||
Net Income Margin % | 3.78 | 4.64 | 6.89 | 0.96 | 7.84 | |||||
Net Avail. For Common Margin % | 3.78 | 4.64 | 6.89 | 4.05 | 2.81 | |||||
Normalized Net Income Margin | 4.06 | 4.06 | 5.54 | 3.66 | 3 | |||||
Levered Free Cash Flow Margin | 9.05 | 7.11 | 5.23 | 4.8 | 7.35 | |||||
Unlevered Free Cash Flow Margin | 9.83 | 7.8 | 5.92 | 5.88 | 8.81 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.08 | 1.11 | 1.12 | 1.03 | 0.97 | |||||
Fixed Assets Turnover | 3.35 | 3.4 | 3.24 | 3.01 | 3.01 | |||||
Receivables Turnover (Average Receivables) | 15.92 | 15.44 | 15.9 | 15.71 | 15.41 | |||||
Inventory Turnover (Average Inventory) | 15.09 | 13.79 | 12.67 | 12.27 | 12.85 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.03 | 1.26 | 1.06 | 1.09 | 1.1 | |||||
Quick Ratio | 0.74 | 0.9 | 0.69 | 0.72 | 0.76 | |||||
Operating Cash Flow to Current Liabilities | 0.61 | 0.74 | 0.8 | 0.57 | 0.67 | |||||
Days Sales Outstanding (Average Receivables) | 22.93 | 23.64 | 22.95 | 23.3 | 23.69 | |||||
Days Outstanding Inventory (Average Inventory) | 24.19 | 26.47 | 28.8 | 29.82 | 28.4 | |||||
Average Days Payable Outstanding | 50.33 | 45.77 | 42.93 | 44.96 | 47.22 | |||||
Cash Conversion Cycle (Average Days) | -3.21 | 4.35 | 8.82 | 8.15 | 4.88 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 95.81 | 86.84 | 77.59 | 110.48 | 82.47 | |||||
Total Debt / Total Capital | 48.93 | 46.48 | 43.69 | 52.49 | 45.2 | |||||
LT Debt/Equity | 91.31 | 82.52 | 72.41 | 105.14 | 77.43 | |||||
Long-Term Debt / Total Capital | 46.63 | 44.17 | 40.77 | 49.95 | 42.43 | |||||
Total Liabilities / Total Assets | 60.56 | 58.05 | 55.16 | 62.25 | 56.66 | |||||
EBIT / Interest Expense | 5.73 | 6.29 | 7.42 | 4.03 | 2.9 | |||||
EBITDA / Interest Expense | 12.4 | 13.18 | 13.33 | 8.59 | 6.53 | |||||
(EBITDA - Capex) / Interest Expense | 10.1 | 9.79 | 8.3 | 5.45 | 4.99 | |||||
Total Debt / EBITDA | 2.11 | 2.11 | 1.78 | 2.66 | 2.22 | |||||
Net Debt / EBITDA | 1.72 | 1.56 | 1.57 | 2.51 | 2.07 | |||||
Total Debt / (EBITDA - Capex) | 2.59 | 2.83 | 2.86 | 4.19 | 2.9 | |||||
Net Debt / (EBITDA - Capex) | 2.11 | 2.1 | 2.52 | 3.95 | 2.71 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 19.24 | 8.65 | 9.76 | 9.92 | 5.4 | |||||
Gross Profit, 1 Yr. Growth % | 30.45 | 7.75 | 9.7 | 7.67 | 6.33 | |||||
EBITDA, 1 Yr. Growth % | 44.38 | 3.14 | 28.21 | -10.4 | 5.61 | |||||
EBITA, 1 Yr. Growth % | 57.25 | 2.07 | 31.15 | -17.5 | 3.22 | |||||
EBIT, 1 Yr. Growth % | 116.76 | 6.73 | 45.56 | -25.73 | 4.18 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 238.6 | 33.16 | 63.04 | -45.11 | -22.67 | |||||
Net Income, 1 Yr. Growth % | 238.6 | 33.16 | 63.04 | -85.2 | 751.61 | |||||
Normalized Net Income, 1 Yr. Growth % | 234.34 | 8.76 | 49.72 | -37.59 | -7.45 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 235.92 | 32.47 | 62.95 | -45.77 | -23.39 | |||||
Accounts Receivable, 1 Yr. Growth % | 21.03 | 4.56 | 8.45 | 7.04 | 5.16 | |||||
Inventory, 1 Yr. Growth % | 4.28 | 34.36 | 8.4 | 11.97 | -10.38 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.27 | 10.87 | 19.25 | 10.37 | -1.42 | |||||
Total Assets, 1 Yr. Growth % | 4.35 | 6.96 | 10.44 | 20.57 | 0.9 | |||||
Tangible Book Value, 1 Yr. Growth % | -40.98 | -102.41 | -44.44 | -15T | -49.26 | |||||
Common Equity, 1 Yr. Growth % | 14.71 | 13.76 | 18.03 | 1.48 | 15.13 | |||||
Cash From Operations, 1 Yr. Growth % | -22.42 | 25.42 | 11.92 | -19.76 | 21.09 | |||||
Capital Expenditures, 1 Yr. Growth % | 45.04 | 42.86 | 83.91 | -6.62 | -33.16 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -26.9 | -14.7 | -19.32 | -13.77 | 69.43 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -25.75 | -13.78 | -16.68 | -4.52 | 63.99 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 7.69 | 7.14 | 6.67 | 6.25 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.02 | 13.82 | 9.2 | 8.07 | 6.92 | |||||
Gross Profit, 2 Yr. CAGR % | 14.62 | 18.56 | 8.72 | 7.81 | 5.21 | |||||
EBITDA, 2 Yr. CAGR % | 25.6 | 22.03 | 15 | 10.51 | -4.32 | |||||
EBITA, 2 Yr. CAGR % | 30.03 | 26.69 | 15.7 | 7.72 | -9.6 | |||||
EBIT, 2 Yr. CAGR % | 60.33 | 52.1 | 24.64 | 8.95 | -14.67 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 53.42 | 112.34 | 47.34 | 1.35 | -36.98 | |||||
Net Income, 2 Yr. CAGR % | 53.42 | 112.34 | 47.34 | -50.88 | 12.26 | |||||
Normalized Net Income, 2 Yr. CAGR % | 68.2 | 90.69 | 27.61 | 2.58 | -27.08 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 52.85 | 110.95 | 46.92 | 0.83 | -37.61 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.44 | 12.5 | 6.48 | 7.74 | 6.1 | |||||
Inventory, 2 Yr. CAGR % | 7.1 | 18.37 | 20.68 | 10.17 | 0.18 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 73.43 | 7 | 14.98 | 14.73 | 4.31 | |||||
Total Assets, 2 Yr. CAGR % | 13.3 | 5.65 | 8.68 | 15.39 | 10.29 | |||||
Tangible Book Value, 2 Yr. CAGR % | -32.31 | -88.07 | -88.42 | 809.82 | 769.48 | |||||
Common Equity, 2 Yr. CAGR % | 8.24 | 14.23 | 15.88 | 9.44 | 8.09 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.59 | -1.36 | 18.48 | -5.24 | -1.43 | |||||
Capital Expenditures, 2 Yr. CAGR % | 16.32 | 43.95 | 62.09 | 31.05 | -21 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 23.03 | -21.04 | -17.04 | -11.19 | 17.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 24.33 | -19.99 | -15.24 | -6.2 | 22.01 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.71 | - | 7.42 | 6.9 | 6.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.94 | 10.88 | 12.45 | 8.26 | 6.7 | |||||
Gross Profit, 3 Yr. CAGR % | 13.54 | 12.28 | 15.53 | 7.79 | 6.12 | |||||
EBITDA, 3 Yr. CAGR % | 18.76 | 17.62 | 24.06 | 8 | 7.66 | |||||
EBITA, 3 Yr. CAGR % | 20.78 | 19.95 | 28.16 | 5.8 | 4.75 | |||||
EBIT, 3 Yr. CAGR % | 32.86 | 39.99 | 49.89 | 8.2 | 5.18 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 21.73 | 46.34 | 94.44 | 11.01 | -9.42 | |||||
Net Income, 3 Yr. CAGR % | 21.73 | 46.34 | 94.44 | -31.51 | 27.13 | |||||
Normalized Net Income, 3 Yr. CAGR % | 34.84 | 45.45 | 75.92 | 4.6 | -3.57 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 19.45 | 45.73 | 93.56 | 10.44 | -9.97 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.09 | 11.05 | 11.13 | 6.67 | 6.87 | |||||
Inventory, 3 Yr. CAGR % | 13.04 | 15.51 | 14.95 | 17.71 | 2.84 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 47.78 | 49.4 | 10.94 | 13.43 | 9.07 | |||||
Total Assets, 3 Yr. CAGR % | 14.95 | 11.15 | 7.22 | 12.51 | 10.34 | |||||
Tangible Book Value, 3 Yr. CAGR % | -6.61 | -77.72 | -80.07 | 25.94 | 247.6 | |||||
Common Equity, 3 Yr. CAGR % | 6.61 | 10.05 | 15.49 | 10.86 | 11.31 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.19 | 22.17 | 2.88 | 4.04 | 2.83 | |||||
Capital Expenditures, 3 Yr. CAGR % | 16.43 | 24.56 | 56.2 | 34.87 | 4.7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 23.3 | 8.89 | -20.47 | -12.37 | 7.89 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 23.72 | 10.05 | -18.9 | -8.8 | 11.11 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.14 | 8.37 | - | 7.17 | 6.69 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 18.52 | 15.31 | 13.2 | 9.75 | 9.49 | |||||
Gross Profit, 5 Yr. CAGR % | 15.95 | 13.94 | 11.59 | 10.47 | 10.93 | |||||
EBITDA, 5 Yr. CAGR % | 19.27 | 14.18 | 17.24 | 14.72 | 13.19 | |||||
EBITA, 5 Yr. CAGR % | 20.14 | 14.24 | 18.72 | 14.9 | 13.03 | |||||
EBIT, 5 Yr. CAGR % | 26.2 | 20 | 29.51 | 26.63 | 21.9 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.49 | 17.45 | 31.39 | 26.34 | 27.36 | |||||
Net Income, 5 Yr. CAGR % | 22.49 | 17.45 | 31.39 | -5.44 | 56.08 | |||||
Normalized Net Income, 5 Yr. CAGR % | 27.49 | 19.95 | 31.9 | 26.49 | 26.67 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 19.12 | 14.55 | 29.76 | 25.77 | 26.56 | |||||
Accounts Receivable, 5 Yr. CAGR % | 22.16 | 23.84 | 18.41 | 9.71 | 9.09 | |||||
Inventory, 5 Yr. CAGR % | 14.99 | 15.95 | 16.04 | 13.34 | 8.79 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 36.35 | 31.86 | 33.67 | 34.42 | 8.24 | |||||
Total Assets, 5 Yr. CAGR % | 18.61 | 14.55 | 12.4 | 12.83 | 8.44 | |||||
Tangible Book Value, 5 Yr. CAGR % | -15.17 | -59.16 | -59.48 | -1.76 | -9.77 | |||||
Common Equity, 5 Yr. CAGR % | 32.61 | 19.83 | 10.23 | 9.81 | 12.47 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.63 | 20.51 | 17.71 | 10.37 | 1.13 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.34 | 11.58 | 32.91 | 27.12 | 18.92 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 21.93 | 20.57 | 5.23 | 0.37 | -4.78 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 22.17 | 20.89 | 6.35 | 3.24 | -2.57 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.18 | 9.24 | 8.45 | 7.78 | - |
- Stock Market
- Stocks
- CVSG Stock
- Financials CVS Group plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















